| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,420,488 | 5,292,554 | 5,797,889 | 6,071,525 | | Cost of Revenue | 5,108,144 | 4,975,649 | 5,448,616 | 5,748,440 | | | Gross Profit | 312,344 | 316,905 | 349,273 | 323,085 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 49,622 | 42,003 | 25,415 | 83,367 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 262,722 | 274,902 | 323,858 | 239,718 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,725 | 5,836 | 7,225 | 14,491 | | Earnings Before Interest And Taxes | 268,447 | 280,738 | 331,083 | 254,209 | | Interest Expense | 2,585 | 2,488 | 2,583 | 2,358 | | Income Before Tax | 265,862 | 278,250 | 328,500 | 251,851 | | Income Tax Expense | 91,858 | 101,911 | 107,213 | 61,754 | | Minority Interest | (35,465) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 138,539 | 176,339 | 221,287 | 190,097 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 138,539 | 176,339 | 221,287 | 190,097 | | Preferred Stock And Other Adjustments | 23,557 | (7,069) | (16,488) |
-
| | | Net Income Applicable To Common Shares | $162,096 | $169,270 | $204,799 | $190,097 |
|
1.52% Nasdaq 0.00%
Income Statement
